Phase II trial and correlative genomic analysis of everolimus plus bevacizumab in advanced non-clear cell renal cell carcinoma Academic Article uri icon

Overview

MeSH Major

  • Carcinoma, Renal Cell
  • Kidney Neoplasms
  • Polymorphism, Single Nucleotide
  • Proto-Oncogene Proteins c-met

abstract

  • The study suggests efficacy for this combination in patients with ncRCC characterized by papillary features. Distinct mutational profiles among ncRCCs vary according to specific histology.

publication date

  • November 10, 2016

Research

keywords

  • Academic Article

Identity

Language

  • eng

Digital Object Identifier (DOI)

  • 10.1200/JCO.2016.67.9084

PubMed ID

  • 27601542

Additional Document Info

start page

  • 3846

end page

  • 3853

volume

  • 34

number

  • 32